| Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4785 | 2013 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10, 1-10, 2012 | 948 | 2012 |
| Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 852 | 2009 |
| Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors Y Lou, PC McDonald, A Oloumi, S Chia, C Ostlund, A Ahmadi, A Kyle, ... Cancer research 71 (9), 3364-3376, 2011 | 765 | 2011 |
| Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ... New England Journal of Medicine 366 (3), 234-242, 2012 | 504 | 2012 |
| Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, ... Nature genetics 46 (5), 438-443, 2014 | 457 | 2014 |
| Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013 | 457 | 2013 |
| Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 P Ramos, AN Karnezis, DW Craig, A Sekulic, ML Russell, WPD Hendricks, ... Nature genetics 46 (5), 427-429, 2014 | 346 | 2014 |
| Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss B Clarke, AV Tinker, CH Lee, S Subramanian, M Van De Rijn, D Turbin, ... Modern Pathology 22 (3), 393-402, 2009 | 331 | 2009 |
| Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses E Kuhn, RC Wu, B Guan, G Wu, J Zhang, Y Wang, L Song, X Yuan, L Wei, ... Journal of the National Cancer Institute 104 (19), 1503-1513, 2012 | 271 | 2012 |
| Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma CB Gilks, DN Ionescu, SE Kalloger, M Köbel, J Irving, B Clarke, J Santos, ... Human pathology 39 (8), 1239-1251, 2008 | 271 | 2008 |
| Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial TL Stockley, AM Oza, HK Berman, NB Leighl, JJ Knox, FA Shepherd, ... Genome medicine 8, 1-12, 2016 | 243 | 2016 |
| Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas MS Anglesio, S Kommoss, MC Tolcher, B Clarke, L Galletta, H Porter, ... The Journal of pathology 229 (1), 111-120, 2013 | 237 | 2013 |
| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 221 | 2014 |
| Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience AJ Evans, R Chetty, BA Clarke, S Croul, DM Ghazarian, TR Kiehl, ... Seminars in diagnostic pathology 26 (4), 165-176, 2009 | 206 | 2009 |
| Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) WG McCluggage, MJ Judge, BA Clarke, B Davidson, CB Gilks, H Hollema, ... Modern pathology 28 (8), 1101-1122, 2015 | 175 | 2015 |
| Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer B Clarke, R Chetty Molecular pathology 55 (1), 19, 2002 | 167 | 2002 |
| Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy CS Lo, S Sanii, DR Kroeger, K Milne, A Talhouk, DS Chiu, K Rahimi, ... Clinical Cancer Research 23 (4), 925-934, 2017 | 161 | 2017 |
| Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate-and high-grade endometrial cancer staging MC Cusimano, D Vicus, K Pulman, M Maganti, MQ Bernardini, ... JAMA surgery 156 (2), 157-164, 2021 | 160 | 2021 |
| Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type BA Clarke, CB Gilks Journal of clinical pathology 63 (5), 410-415, 2010 | 147 | 2010 |
